Predictive Oncology Inc. (AGPU)
NASDAQ · Technology
Predictive Oncology Inc. Revenue 2017–2025
Predictive Oncology Inc. annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Predictive Oncology Inc. revenue for the quarter ending March 31, 2026 was 35311, a 67.99% decrease year-over-year.
- Predictive Oncology Inc. revenue for the twelve months ending March 31, 2026 was 151921, a 79.82% decrease year-over-year.
- Predictive Oncology Inc. annual revenue for 2025 was 125284, a 47.72% increase from 2024.
- Predictive Oncology Inc. annual revenue for 2024 was 84812, a 94.79% decrease from 2023.
- Predictive Oncology Inc. annual revenue for 2023 was 1.6 M, a 8.12% increase from 2022.
- Predictive Oncology Inc. annual revenue for 2022 was 1.5 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Predictive Oncology Inc. Market Cap — FAQ
Predictive Oncology Inc. (AGPU) market cap over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AGPU's market cap history?
The chart and table above show Predictive Oncology Inc.'s market cap by year and by quarter, including the growth rate.